Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Litmus Health Announces Advisory Board as Real-Life Data Gain Traction in Clinical Trials
  • USA - English


News provided by

Jones-Dilworth, Inc.

Jul 20, 2017, 10:00 ET

Share this article

Share toX

Share this article

Share toX


AUSTIN, TX (PRWEB) July 20, 2017 -- Litmus Health, a clinical data science platform focused on health-related quality of life, today announced its full advisory board. The board comprises leaders spanning business, technology, academia, and pharmaceutical research. The company also announced the promotion of James Crooks, PhD, former VP of Engineering, to Chief Technology Officer. Crooks will lead strategy and development of the Litmus platform.

The Litmus Health advisory board will offer expert guidance in helping Litmus realize the power of real-life data to improve trial endpoints and create better results through faster, more efficient research and development pipelines.

Post this

With advances in remote monitoring devices such as wearables and other home sensors, individuals are creating more data at the point of experience than ever before. The challenge is successfully capturing and using it. Far too often in today’s clinical trials, researchers draw conclusions without data on what’s happening outside the controlled setting of the clinic.

The Litmus Health advisory board will offer expert guidance in helping Litmus realize the power of real-life data to improve trial endpoints and create better results through faster, more efficient research and development pipelines.

“The industry is under increasing pressure to get drugs to market faster and demonstrate more value. It’s imperative now more than ever to bring together top minds from multiple disciplines to help shape the future of clinical trials,” said Daphne Kis, CEO of Litmus Health. “We’re proud to have brought together such an impressive group of individuals who are committed to helping Litmus make the greatest impact possible.”

Since its public launch in October 2016, Litmus Health has continued to build out its data science platform to help bring real-life data and health-related quality-of-life information to the forefront of clinical research. The company is helping researchers realize the full value of their work from observational studies, therapeutic trials, and post-market research by uncovering fundamentally new insights from patient data.

“Medical research, like health care broadly, needs to start paying attention to what happens outside its own walls,” said Esther Dyson, Litmus Health advisory board member and executive founder of Way to Wellville. “Specifically, people’s behavior and environment have a huge influence on their health and on their response to disease agents, whether chronic or infectious. We will soon wonder how we could have conducted research without assessing external factors – just as a farmer might consider the weather. I’m delighted to be working with Daphne and her team in a company that is leading the way.”

The company also announced the promotion of James Crooks, PhD, from VP of Engineering to Chief Technology Officer. His unique contributions to product management and product development since the beginning have been paramount in creating the foundation for the Litmus platform. Prior to Litmus, Crooks trained at the University of Chicago as a computational biophysicist and data scientist dedicated to developing tools that improve biomedical research. Now, he will lead Litmus’s technical organization.

“The ability to span both disciplines of data science and life science is paramount for clinical research,” said Dr. Sam Volchenboum, Chief Medical Officer of Litmus Health. “James brings to the table the full spectrum, and has helped build our platform from the ground up. He is a huge asset both technologically and strategically, and we’re lucky to have him.”

The Litmus platform is currently being piloted at the University of Chicago in a clinical trial run by gastroenterologist Dr. David Rubin on the effects of activity, sleep, and diet on patients with Inflammatory Bowel Disease (IBD).

About Litmus Health’s Advisory Board:

The Litmus Health advisory board is made up of thought leaders dedicated to the power of real-life data collected at the point of experience to create faster, more efficient research and development pipelines.

Esther Dyson is executive founder of the Way to Wellville and chairman of EDventure Holdings, and a prolific angel investor. She is a long-time collaborator with Litmus co-founder Daphne Kis, as they spent 18 years working together on PC Forum and Release 1.0. Esther brings to Litmus decades of experience in advising and managing startups in health and digital technology.

Dr. Rebecca Kush is the founder and former CEO of CDISC (the Clinical Data Interchange Standards Consortium) and now the Scientific Innovation officer of Elligo Health Research. Becky has dedicated more than 20 years of her life to understanding and improving the science of clinical trials.

Dr. Sam Blackman is a pediatric oncologist and Vice President of Silverback Therapeutics. Sam has worked at Merck, GlaxoSmithKline, and Juno Pharmaceuticals and brings to Litmus a wealth of knowledge of how pharmaceutical companies design and run clinical trials.

Dr. David Rubin is an internationally recognized gastroenterologist specializing in inflammatory bowel disease. At the University of Chicago, he runs a research group focused on bettering our understanding and treatment of Crohn’s disease and ulcerative colitis. He is Co-Director of the University of Chicago Digestive Diseases Center.

Richard Schwartz has spent his career building and leading technology companies to commercial success and acquisition by some of the biggest names in the industry. He holds a PhD in Computer Science from UCLA and has served as a senior computer scientist at Stanford Research Institute (SRI International), prior to founding his first company.

Professor Ian Foster was the long-time Director of the Computation Institute at the University of Chicago and is a distinguished fellow and senior scientist in the Mathematics and Computer Science Division at Argonne National Laboratory, and a professor in the Department of Computer Science at the University of Chicago. Dr. Foster led the development of the field of grid computing, which ultimately paved the way for the emergence of cloud computing.

To learn more about the new Litmus Health Advisory Board, please visit The Litmus Papers.

For more about Litmus Health, please visit: http://www.litmushealth.com

About Litmus Health:

Litmus is a clinical data science platform focused on health-related quality of life.

We use data collected at the point of experience from wearables, smart devices, and home sensors to guide management and to inform trial endpoints. Continuously measuring outcomes in multiple dimensions leads to faster, more efficient pipelines.

The answers we need are all around us. Learn more at http://www.litmushealth.com

Alexa Ball, Jones-Dilworth, Inc., +1 2179531638, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.